Park Linda 4

What Happened
Linda Park, a director of BIOLARGO, Inc. (BLGO), was granted a derivative award (an option) on 2026-06-30 covering 165,198 shares. The option was issued as payment for $18,750 of fees owed to Park for her board services under the company's 2024 Equity Incentive Plan. The filing reports the award but does not disclose an exercise price or immediate cash value for the option.

Key Details

• Transaction date: 2026-06-30; Form 4 filed 2026-07-02 (reporting date).
• Transaction type: Award/Grant (derivative option); 165,198 shares reported as the option's underlying shares.
• Monetary equivalent disclosed in footnote: option issued in lieu of $18,750 in director fees.
• Exercise price: not disclosed in the Form 4; the footnote says the number of option shares equals fees due divided by the option exercise price.
• Shares owned after transaction: not reported in the filing.
• Footnote (F1): Option issued as payment for board fees under the 2024 Equity Incentive Plan. No vesting, exercise schedule, or sale of shares is described.

Context
This was a compensation grant (an option issued in lieu of cash fees), not an open-market purchase or sale. Such awards compensate service and do not by themselves signal a buy or sell decision by the insider. If you track insider activity, purchases are generally more informative than compensation awards; check future filings for any exercises or sales related to this option.